Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASEL | Q05823 | 8/20 | 0.43 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.42 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | CHAT | P28329 | 1/20 | 0.40 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.40 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.40 |
| ▸ | NAA50 | Q9GZZ1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16288671 | 1.00 | RNASEL (0.43) | RNASELENPP1AURKACHATEP300 | |
| SCHEMBL29540015 | 1.00 | RNASEL (0.43) | RNASELENPP1AURKACHATEP300 | |
| SCHEMBL16288679 | 1.00 | RNASEL (0.43) | RNASELENPP1AURKACHATEP300 | |
| SCHEMBL16288668 | 1.00 | RNASEL (0.43) | RNASELENPP1AURKACHATEP300 | |
| SCHEMBL23039203 | 1.00 | RNASEL (0.43) | RNASELENPP1AURKACHATEP300 | |
| SCHEMBL16288674 | 1.00 | RNASEL (0.43) | RNASELENPP1AURKACHATEP300 | |
| SCHEMBL16574850 | 1.00 | RNASEL (0.43) | RNASELENPP1AURKACHATEP300 | |
| SCHEMBL16578284 | 1.00 | RNASEL (0.43) | RNASELENPP1AURKACHATEP300 | |
| SCHEMBL21952424 | 0.94 | RNASEL (0.47) | RNASELENPP1 | |
| SCHEMBL15083421 | 0.94 | RNASEL (0.44) | RNASELENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2813512-B1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2021-03-31 | — | — | EP | disclosed |